Heart Foundation Pharmaceutical Roundtable

The Heart Foundation Pharmaceutical Roundtable (the Roundtable) brings together members of leading pharmaceutical companies to help improve the cardiovascular health of Australians.  Since its inception, the Roundtable has contributed about $4 million towards advancing cardiovascular research.

This collaboration also offers members a unique opportunity to participate in and develop new evidence based consumer health education and prevention projects together with the Heart Foundation, with a particular focus on Quality Use of Medicines (QUM) and adherence.

The Heart Foundation acknowledges the Roundtable as a unique opportunity to provide sector leadership and a productive alliance, delivering mutual benefits to the member companies and the Heart Foundation as well as improved health outcomes for the public. 

 

Click here to visit the Heart Foundation website